Match Document Document Title
7785602 Recombinant porcine adenovirus vector  
This invention relates to a recombinant vector including a recombinant porcine adenovirus, stably incorporating and capable of expression of at least one heterologous nucleotide sequence. The...
7785887 Adenovirus E1B-55K single amino acid mutants and methods of use  
Adenoviral mutants are described that have single amino acid mutations in the E1B-55K protein which mutations effect the p53 binding/inactivation and the late functions of the E1B-55K protein in a...
7780961 Self-containing Lactococcus strain  
The invention relates to a recombinant Lactococcus strain, with environmentally limited growth and viability. More particularly, it relates to a recombinant Lactococcus that can only survive in...
7776321 Mutable vaccines  
The invention relates to methods and materials useful for targeting antigenic determinants of mutable pathogens for somatic hypermutation. These methods and materials can be used to induce an...
7776320 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex  
A protocol for use of growth factors to stimulate neuronal cell growth and activity in trkB receptor containing cortical tissues, including the entorhinal and hippocampal cortices. The method...
7776323 Streptococcus suis vaccines and diagnostic tests  
The invention relates to Streptococcus suis infection in pigs, vaccines directed against those infections and tests for diagnosing Streptococcus suis infections. The invention provides an...
7776322 Modified viral vector particles  
This invention relates to viral vector particles, including capsid proteins with an attachment site for the specific chemical modification of the vector particles. Furthermore, the invention...
7776592 Human renal stem cells  
The present disclosure provides human renal stem cells. Also described are human renal stem cells isolated from the papillary region of the human kidney and methods of isolating the same. Also...
7772205 Gene therapy for renal failure  
The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also...
7771967 Nucleic acid encoding apolipoprotein E-I3  
The present invention provides nucleic acids comprising a nucleotide sequence encoding an apolipoprotein E (apoE) splice variant, e.g., an unprocessed apoE, that retains intron 3; and vectors and...
7767202 Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules  
The invention provides methods and compositions for the modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen...
7758855 DNA promoters and anthrax vaccines  
The invention is related to intracellularly induced bacterial DNA promoters and vaccines against Bacillus anthracis.
7758854 Anti-microbial agents  
Antimicrobial agents that can serve as replacements to conventional pharmaceutical antibiotics are disclosed. The antimicrobial agents comprise conjugatively transmissible plasmids that kill...
7754467 Surface expression of biologically active proteins in bacteria  
Methods and compositions for targeting heterologous polypeptides to bacterial cell walls are provided.
7754482 Artificial antigen presenting cells and uses therefor  
The invention relates to novel artificial antigen presenting cells (aAPCs). The aAPC comprises at least one stimulatory ligand and at least one co-stimulatory ligand where the ligands each...
7749510 Methods of eliciting or boosting a cellular immune response  
Site-specific Listeria integration vectors and methods for their use are provided. The subject vectors include a bacteriophage integrase gene and a bacteriophage attachment site, where in many...
7749745 Viral vectors and their use in therapeutic methods  
The invention provides viral vectors (e.g., herpes viral vectors) and methods of using these vectors to treat disease.
7749493 Chimeric adenoviruses  
The present invention provides methods and vector systems for the generation of chimeric recombinant adenoviruses. These hybrid adenoviruses contain a genome that is derived from different...
7749492 AAV vectors and methods  
The invention relates to Adeno-associated virus vectors. In particular, it relates to Adeno-associated virus vectors with modified capsid proteins and materials and methods for their preparation...
7745416 Method for in vivo regulation of cardiac muscle contractility  
A method for regulating in vivo calcium transport in cardiac muscle of animals suffering from congestive heart failure is disclosed. According to the method, calcium ATPase activity (which...
7745214 Methods of obtaining neural stem cells  
A transgenic, non-human mammal useful for assessing the effect of candidate chemotherapeutic drugs on the growth of brain tumors in vivo is provided. Incorporated into the genome of the transgenic...
7745698 Peptide extension for enhancement of transgene expression in chloroplasts  
The invention provides a novel method of controlling gene expression in plastids, using a peptide extension that can be fused to a desired protein, expression cassettes that include the genetic...
7745700 Insecticidal proteins derived from Bacillus thuringiensis  
The present invention relates to the field of plant pest control, particularly insect control. Provided are nucleotide sequences from Bacillus thuringiensis encoding insecticidal proteins....
7740864 Vaccines for diseases of fish  
Fish are immunized by a mass vaccination method, such as by immersion in water containing an attenuated strain of a pathogenic bacterium that does not effectively cause disease in fish when the...
7740835 Anaerobic bacterium as a drug for cancer gene therapy  
The present invention provides a bacterium belonging to the genus Bifidobacterium , by which DNA coding for a protein having an antitumor activity or DNA coding for a protein having the activity...
7740836 Methods and compositions for recovering or improving visual function  
There are disclosed methods and compositions for recovering or improving visual function in a mammal, by means of adeno-associated viral vectors suitable for gene delivery to mammalian retina.
7740867 Method for identification of virulence determinants  
Disclosed are methods for the determination of virulence determinants in bacteria and in particular bacteria of the genus Mycobacterium . Also disclosed are compositions and methods for...
7736641 Role for SRY in Parkinson's disease  
The present invention relates to a method for treating or preventing Parkinson's disease in a patient, the method comprising administering to the patient a therapeutically effective population of...
7736640 Methods of treating and detecting cancer using viruses  
The invention provides a method of treating cancer in a mammal comprising administering to the mammal an effective amount of virus, particularly Newcastle Disease Virus or other Paramyxovirus. The...
7737331 Bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof  
The present invention provides insecticidal polypeptides related to Bacillus Cry2 polypeptides. Nucleic acids encoding the polypeptides of the invention are also provided. Methods for using the...
7731952 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response  
The present invention relates to an avirulent, oncolytic herpes simplex virus modified from a wild-type herpes simplex virus so that both γ 1 34.5 genes of the virus have been deleted and each...
7732203 Method for transdifferentiating mesenchymal stem cells into neuronal cells  
This inventive discloses a method for transdifferentiating mesenchymal stem cells into neuronal cells, which comprises increasing the level of a basic helix-loop-helix (bHLH) transcription factor...
7727522 Lentiviral vectors derived from SIVsmm/PBj14, method for their production and uses thereof  
The invention relates to retroviral vectors (known as lentiviral vectors), which are used to transfer genes into cells that are at cell cycle stage G0, to methods for their production and to the...
7727971 Use of placental growth factor for treating ischemic muscle disease  
The present invention relates to prevention and treatment of strokes and ischemic diseases and to post-ischemic therapeutic treatment. The invention furthermore relates to the use of a growth...
7727543 Biodegradable carrier and method for preparation thereof  
A biodegradable carrier is produced for preservation and/or controlled delivery of biologically active agents where said biodegradable carrier is a silica xerogel which is made from water and...
7723111 Activated dual specificity lymphocytes and their methods of use  
The present invention relates to preventive, therapeutic, and diagnostic compositions and methods employing lymphocytes having T-cell receptors and chimeric receptors. In particular, the invention...
7722861 Attenuated Mycobacterium tuberculosis vaccines  
Non-naturally occurring mycobacteria in the Mycobacterium tuberculosis complex are provided. These mycobacteria have a deletion of an RD1 region or a region controlling production of a vitamin,...
7723564 Compositions and methods for modulation of KSR1 and KSR2 interactions  
Materials and methods for identifying agents which modulate KSR mediated signal transduction are provided.
7722860 Live genetically engineered protozoan vaccine  
The invention provides methods for inducing an immune response in a vertebrate host against a protozoan parasite, comprising administering to the host a live protozoan parasite that is genetically...
7718165 Live genetically attenuated malaria vaccine  
Method for inoculating a vertebrate host against malaria, by administering to the host a live Plasmodium organism that is genetically engineered to disrupt a liver-stage-specific gene function.
7718626 ErbB3 binding protein compositions and methods of use  
A method of repressing a cell-cycle gene, which is regulated by an E2F transcription factor, in a cell, wherein the method comprises contacting the cell with a cell-cycle gene-repressing amount of...
7708986 Targeted vectors for cancer immunotherapy  
This invention provides compositions and methods for treating cancer. More specifically this invention is directed to a targeted retroviral vector comprising a cytokine gene that can be...
7708977 Method for diagnosis and treatment of vascular disease  
A method for diagnosing decreased vascular function is disclosed. The method includes assaying the number of endothelial progenitor cells. A method for detecting increased cardiovascular risk is...
7709457 Methods and compositions for delivery of pharmaceutical agents  
Methods and compositions for delivering pharmaceutical agents into cells, in particular urothelial cells of the bladder, are provided. In the methods and compositions of the invention, a...
7704493 Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures  
This invention provides a composition for delivery of a gene to a syncytial structure comprising stem cells incorporated with the gene. This invention also provides a composition for ion channel...
7704964 Methods and compounds for the targeting of protein to exosomes  
The present invention relates to compositions and methods for selectively expressing a polypeptide in a membrane vesicle. The invention also relates to genetic constructs and recombinant cells...
7704272 Method for introducing an ultraviolet light activated viral vector into the spinal column  
In accordance with the present invention, methods and structures are provided for the treatment of functional spinal unit injuries through the use of light activated gene therapy to induce bone...
7704491 Recombinant human metapneumovirus and its use  
Recombinant HMPV (rHMPV) and related immunogenic compositions and methods are provided. The rHMPVs, including chimeric and chimeric HMPV vectors viruses, provided according to the current...
7700574 Modulation of RANKL expression  
Compounds, compositions and methods are provided for modulating the expression of RANKL. The compositions comprise oligonucleotides, targeted to nucleic acid encoding RANKL. Methods of using these...
7700090 Co-culture of placental stem cells and stem cells from a second source  
The present invention relates to a combination of placental stem cells and stem or progenitor cells derived from a second source, wherein the combination shows improved engraftment as compared to...